Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GDTC
#4824
CytoMed Therapeutics Limited Ordinary Shares
1.0
0
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-1.96%
6 month change
-53.92%
Year Change
-58.68%
Previous Close
1.0
0
Open
1.0
0
Bid
Ask
Low
1.0
0
High
1.0
0
Volume
3
Markets
US Stock Market
Healthcare
GDTC
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2022
2023
2024
2025
TTM
Cash from operating activities
-1.04 M
-2.6 M
-1.98 M
-2.88 M
—
Cash from investing activities
-353.11 K
-2.14 M
824.58 K
722.67 K
—
Cash from financing activities
722.71 K
8.28 M
-47.5 K
162.26 K
—
Free cash flow
-1.04 M
-2.6 M
-1.98 M
-2.88 M
—
News
CytoMed stock jumps after announcing clinical trial partnership in Malaysia
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital
CytoMed Therapeutics secures $500,000 investment for subsidiary
CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript
CytoMed reports promising preclinical results for leukemia treatment
CytoMed Therapeutics shareholders approve all proposals at annual meeting
CytoMed Therapeutics schedules annual shareholder meeting